Alzheimer’s disease (AD), a common neurodegenerative disease, is characterized by low levels in the brain of the neurotransmitter, acetylcholine (ACh). Clinical treatment of this disease is palliative and relies mostly on enhancing cholinergic function by stimulation of cholinergic receptors or prolonging the availability of ACh released into the neuronal synaptic cleft by use of agents which restore or improve the levels of acetylcholine. Inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), enzymes which breakdown acetylcholine, are considered as a promising strategy for the treatment of AD. A potential source of AChE and BChE inhibitors is provided by the abundance of plants in nature, and natural products continue ...
Objective: The aim of this study is to discover and identify the potential plant extracts that could...
Many Bangladeshi medicinal plants have been used to treat Alzheimer's disease and other neurodegener...
Alzheimer’s disease (AD) is a neurodegenerative disorder manifested by decline in memory and mild co...
Alzheimer’s disease (AD), a common neurodegenerative disease, is characterized by low levels in the ...
Abstract: As acetylcholinesterase (AChE) inhibitors are an important therapeutic strategy in Alzheim...
Alzheimer’s disease (AD) is one of the most common and pro-gressive neurodegenerative disorders with...
Alzheimer’s disease (AD) is a progressive, neurodegenerative pathology that primarily affects the el...
Alzheimer’s disease (AD) has been linked with oxidative stress, acetylcholine deficiency in the brai...
Alzheimer's disease (AD) is a neurodegenerative disease characterized by cognite impairment and pers...
Cholinesterase catalyzes the hydrolysis of acetylcholine in the synapse, into choline and acetic aci...
Abstract: Acetylcholinesterase (AChE) (EC 3.1.1.7) is an important enzyme that breaks down of acetyl...
Alzheimer's disease (AD) is a main cause of dementia, accounting for up to 75% of all dementia cases...
Considering the increase of the elderly population in recent years, the growing prevalence of age-re...
PubMed ID: 25475979Studies on Alzheimer's disease have been highlighted due to increasing prevalence...
Many Bangladeshi medicinal plants have been used to treat Alzheimer's disease and other neurodegener...
Objective: The aim of this study is to discover and identify the potential plant extracts that could...
Many Bangladeshi medicinal plants have been used to treat Alzheimer's disease and other neurodegener...
Alzheimer’s disease (AD) is a neurodegenerative disorder manifested by decline in memory and mild co...
Alzheimer’s disease (AD), a common neurodegenerative disease, is characterized by low levels in the ...
Abstract: As acetylcholinesterase (AChE) inhibitors are an important therapeutic strategy in Alzheim...
Alzheimer’s disease (AD) is one of the most common and pro-gressive neurodegenerative disorders with...
Alzheimer’s disease (AD) is a progressive, neurodegenerative pathology that primarily affects the el...
Alzheimer’s disease (AD) has been linked with oxidative stress, acetylcholine deficiency in the brai...
Alzheimer's disease (AD) is a neurodegenerative disease characterized by cognite impairment and pers...
Cholinesterase catalyzes the hydrolysis of acetylcholine in the synapse, into choline and acetic aci...
Abstract: Acetylcholinesterase (AChE) (EC 3.1.1.7) is an important enzyme that breaks down of acetyl...
Alzheimer's disease (AD) is a main cause of dementia, accounting for up to 75% of all dementia cases...
Considering the increase of the elderly population in recent years, the growing prevalence of age-re...
PubMed ID: 25475979Studies on Alzheimer's disease have been highlighted due to increasing prevalence...
Many Bangladeshi medicinal plants have been used to treat Alzheimer's disease and other neurodegener...
Objective: The aim of this study is to discover and identify the potential plant extracts that could...
Many Bangladeshi medicinal plants have been used to treat Alzheimer's disease and other neurodegener...
Alzheimer’s disease (AD) is a neurodegenerative disorder manifested by decline in memory and mild co...